SeaStar Medical Holding Corporation (ICU) vs Passage Bio, Inc. (PASG)

SeaStar Medical Holding Corporation and Passage Bio, Inc. are both Biotechnology companies. SeaStar Medical Holding Corporation and Passage Bio, Inc. are of similar size ($15.5M and $15.2M). Passage Bio, Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, SeaStar Medical Holding Corporation leads on 6 and Passage Bio, Inc. on 6.

Valuation

Metric ICU PASG Biotechnology median
P/E n/m n/m 7.88
P/S 8.15 n/m 11.47
P/B 3.25 3.46 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.23 0.74
EV/Sales 5.59 n/m 10.73
Earnings yield (114.33%) (235.83%) (28.84%)
Free cash flow yield (98.04%) (236.83%) (23.03%)

Profitability

Metric ICU PASG Biotechnology median
Gross margin 92.64% 0.00% 65.16%
Operating margin (816.75%) 0.00% 0.00%
Net margin (795.50%) 0.00% 0.00%
Free cash flow margin (799.36%) 0.00% 0.00%
Return on equity (356.87%) (169.09%) (57.72%)
Return on assets (160.02%) (69.20%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ICU PASG Biotechnology median
Revenue growth (TTM) 123.63% — 5.64%
EPS growth (last fiscal year) 91.16% 32.94% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICU PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.89 1.22 4.73
Net debt to EBITDA 0.99 0.96 0.96

Dividend

Metric ICU PASG Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ICU PASG Biotechnology median
Market cap 15.16m 15.45m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack